FRTY vs. XBI ETF Comparison

Comparison of Alger Mid Cap 40 ETF (FRTY) to SPDR S&P Biotech ETF (XBI)

FRTY

Alger Mid Cap 40 ETF

FRTY Description

The investment seeks long-term capital appreciation. Under normal circumstances, the fund invests at least 80% of its net assets in equity securities of mid-cap companies. Equity securities include common or preferred stocks that are listed on U.S. exchanges. It may invest a significant portion of its assets in the securities of companies conducting business in the information technology and healthcare sectors. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$16.01

Average Daily Volume

16,463

Number of Holdings ^*

* may have additional holdings in another (foreign) market

XBI

SPDR S&P Biotech ETF

XBI Description

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a replication strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Grade (RS Rating)

Last Trade

$99.06

Average Daily Volume

8,049,497

Number of Holdings ^*

125

* may have additional holdings in another (foreign) market

Performance

Period	FRTY	XBI
30 Days	-0.04%	6.47%
60 Days	-0.32%	11.28%
90 Days	2.16%	12.27%
12 Months	21.18%	19.09%

4 Overlapping Holdings

Symbol	Grade	Weight in FRTY	Weight in XBI	Overlap
EXAS	D	2.39%	2.81%	2.39%
NTRA	D	4.07%	2.19%	2.19%
PCVX	C	2.03%	1.03%	1.03%
SRPT	C	1.0%	2.81%	1.0%

FRTY Overweight 35 Positions Relative to XBI

Symbol	Grade	Weight
VRT	D	6.51%
HEI	A	4.59%
MU	D	4.22%
SHAK	D	3.24%
TDG	C	3.15%
MANH	B	3.13%
DKNG	F	3.05%
RRX	C	2.78%
GTES	B	2.73%
APPF	D	2.54%
SPOT	A	2.54%
FANG	B	2.53%
OKTA	C	2.49%
MPWR	B	2.46%
OSCR	D	2.06%
APO	A	1.97%
RBLX	C	1.83%
RGEN	C	1.82%
HUBS	F	1.81%
BURL	A	1.8%
CEG	D	1.79%
PSTG	D	1.77%
PTC	D	1.76%
DDOG	F	1.73%
TWLO	D	1.63%
VLTO	A	1.63%
HCP	A	1.61%
ELF	D	1.61%
MELI	C	1.42%
ONON	C	1.33%
SAIA	D	1.31%
GEV	D	1.16%
PLTR	C	1.16%
CRWD	F	1.13%
SMCI	F	0.53%

FRTY Underweight 121 Positions Relative to XBI

Symbol	Grade	Weight
GILD	C	-3.03%
UTHR	C	-2.96%
AMGN	C	-2.82%
ABBV	A	-2.79%
VRTX	B	-2.64%
REGN	B	-2.62%
INCY	C	-2.61%
VKTX	C	-2.58%
ALNY	C	-2.58%
BMRN	D	-2.55%
NBIX	C	-2.32%
BIIB	F	-2.31%
CYTK	C	-2.15%
MRNA	D	-2.14%
CRSP	D	-1.4%
MDGL	B	-1.39%
BPMC	D	-1.38%
APLS	F	-1.29%
KRYS	B	-1.15%
RVMD	C	-1.14%
IONS	C	-1.14%
EXEL	B	-1.11%
CERE	A	-1.11%
INSM	C	-1.11%
ALKS	C	-1.08%
HALO	B	-0.99%
BBIO	F	-0.96%
TGTX	C	-0.88%
DYN	C	-0.85%
IOVA	D	-0.82%
CRNX	C	-0.8%
SWTX	F	-0.78%
TWST	C	-0.78%
RARE	C	-0.77%
ACAD	D	-0.77%
NTLA	D	-0.75%
ACLX	C	-0.72%
BEAM	C	-0.71%
NUVL	C	-0.69%
IDYA	C	-0.69%
RNA	C	-0.67%
CLDX	C	-0.63%
FOLD	D	-0.63%
GERN	C	-0.62%
MORF	B	-0.58%
ARWR	C	-0.57%
VERA	D	-0.57%
IMVT	D	-0.55%
SNDX	C	-0.54%
KYMR	B	-0.53%
DNLI	C	-0.5%
AGIO	C	-0.49%
ARDX	F	-0.48%
DVAX	F	-0.48%
BCRX	C	-0.47%
RYTM	C	-0.47%
VCEL	C	-0.46%
ADMA	C	-0.46%
PTCT	D	-0.45%
AKRO	D	-0.44%
RXRX	F	-0.43%
CPRX	C	-0.43%
JANX	F	-0.43%
NVAX	D	-0.43%
KROS	C	-0.4%
PTGX	C	-0.39%
NRIX	C	-0.39%
RCKT	D	-0.39%
MIRM	C	-0.38%
IRWD	D	-0.36%
KURA	D	-0.35%
VCYT	C	-0.35%
MYGN	B	-0.35%
ARQT	C	-0.34%
VRDN	C	-0.33%
PRTA	D	-0.31%
DAWN	C	-0.31%
XNCR	F	-0.27%
CGEM	D	-0.27%
SANA	F	-0.27%
MNKD	C	-0.27%
CDMO	C	-0.26%
ARCT	F	-0.25%
TVTX	C	-0.24%
COGT	C	-0.24%
SMMT	C	-0.24%
IMNM	C	-0.24%
CDNA	B	-0.23%
ANAB	C	-0.23%
OLMA	C	-0.22%
RLAY	D	-0.22%
FDMT	F	-0.22%
RCUS	D	-0.21%
CGON	C	-0.21%
RGNX	D	-0.2%
VIR	C	-0.2%
ALT	F	-0.19%
AVXL	C	-0.19%
FATE	C	-0.18%
ETNB	D	-0.18%
ORIC	C	-0.18%
SAGE	F	-0.18%
SRRK	F	-0.17%
ALLO	D	-0.17%
CCCC	C	-0.16%
EDIT	D	-0.16%
STOK	C	-0.16%
OCGN	D	-0.16%
IRON	D	-0.14%
VERV	D	-0.14%
MDXG	C	-0.14%
SPRY	C	-0.13%
HUMA	B	-0.12%
SCLX	D	-0.12%
VYGR	C	-0.11%
CABA	F	-0.1%
HRTX	D	-0.1%
ITOS	B	-0.09%
ALEC	C	-0.09%
ZNTL	F	-0.09%
SVRA	C	-0.08%